Literature DB >> 15062594

Bronchoalveolar lavage in drug-induced lung disease.

Ulrich Costabel1, Esra Uzaslan, Josune Guzman.   

Abstract

Given the varying histologic reactions and differ-ent mechanisms of action, it is not surprising that no uniform constellation of BAL changes is seen in drug-induced lung disease. BAL findings are not specific for any drug-induced lung disease and the definitive diagnosis cannot rely solely on the BAL findings. BAL findings can, however, contribute to the expected clinicopathologic pattern of a given drug-induced lung disease. BAL also is helpful in the differential diagnosis, primarily in the exclusion of an infective cause and of involvement of the lungs by the underlying disease (eg, metastatic cancer or malignant lymphoma).

Entities:  

Mesh:

Year:  2004        PMID: 15062594     DOI: 10.1016/S0272-5231(03)00143-6

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  22 in total

1.  [Bronchoalveolar lavage].

Authors:  M Tötsch; J Guzman; D Theegarten; K W Schmid; U Costabel
Journal:  Pathologe       Date:  2007-09       Impact factor: 1.011

2.  Late-onset methotrexate-induced pneumonitis with neutrophilia in bronchoalveolar lavage fluid.

Authors:  Hideaki Yamakawa; Masahiro Yoshida; Masamichi Takagi; Kazuyoshi Kuwano
Journal:  BMJ Case Rep       Date:  2014-09-29

Review 3.  Diagnosis and management of interstitial pneumonitis associated with interferon therapy for chronic hepatitis C.

Authors:  Fan-Pu Ji; Zheng-Xiao Li; Hong Deng; Hong-An Xue; Yuan Liu; Min Li
Journal:  World J Gastroenterol       Date:  2010-09-21       Impact factor: 5.742

4.  The bronchoalveolar lavage pattern in radiation pneumonitis secondary to radiotherapy for breast cancer.

Authors:  Claudia Lucia Toma; Aneta Serbescu; Mihai Alexe; Luminita Cervis; Diana Ionita; Miron Alexandru Bogdan
Journal:  Maedica (Buchar)       Date:  2010-12

Review 5.  Interstitial lung disease: the diagnostic role of bronchoscopy.

Authors:  Jad Kebbe; Tony Abdo
Journal:  J Thorac Dis       Date:  2017-09       Impact factor: 2.895

6.  Diphenylhydantoin (phenytoin)-induced chronic pulmonary disease.

Authors:  Ramakant Dixit; Kalpana Dixit; Paras Nuwal; Arunima Banerjee; Sidharth Sharma; Lokendra Dave
Journal:  Lung India       Date:  2009-10

7.  Rituximab-induced hypersensitivity pneumonitis.

Authors:  Adriano R Tonelli; Richard Lottenberg; Robert W Allan; P S Sriram
Journal:  Respiration       Date:  2008-10-09       Impact factor: 3.580

8.  Pulmonary fibrosis associated with psychotropic drug therapy: a case report.

Authors:  Clare Thornton; Toby M Maher; David Hansell; Andrew G Nicholson; Athol U Wells
Journal:  J Med Case Rep       Date:  2009-11-16

Review 9.  Busulfan-Induced Lung Injury in Pediatric Oncology Patients-Review of the Literature with an Illustrative Case.

Authors:  Nusa Matijasic; Aleksandra Bonevski; Visnja Tokic Pivac; Ivan Pavic
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2019-09-17       Impact factor: 1.349

10.  Epoprostenol-associated pneumonitis: diagnostic use of a T-cell proliferation assay.

Authors:  Kristina T Kudelko; Kari Nadeau; Ann N Leung; Juliana Liu; François Haddad; Roham T Zamanian; Vinicio De Jesus Perez
Journal:  J Heart Lung Transplant       Date:  2010-06-08       Impact factor: 10.247

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.